RxDoctor Payments Data

Risha Fennell

Addiction Medicine · Normal, ILNPI 1487622379

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,034 and has fallen 94.9% since, to $53 in 2025.

$1,212in general payments, 2019–2025

Across 107 payments — averaging $11.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$234
  • Boehringer Ingelheim$182
  • Johnson & Johnson$156
  • GSK$144
  • Lilly USA, LLC$131
  • Mylan Specialty L.p.$64
  • plus $301 from 11 others

What the payments were for

  • Food & beverage$1,212100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,212 in reported general payments places this provider in the 75th percentile of 47 addiction medicine providers in Illinois.

See all addiction medicine providers in Illinois

Other addiction medicine in Normal

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →